ReviewParasite (Paris, France)2026
From Asia to Europe: epidemiology, genetic diversity, and One Health implications of Thelazia callipaeda.
Review in Parasite (Paris, France), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Thelazia callipaeda, commonly known as the oriental eyeworm, is a vector-borne parasitic nematode that infects the ocular tissues of a wide range of mammalian hosts, including dogs, cats, wildlife, and humans. Historically confined to East and Southeast Asia, T. callipaeda has emerged over the past 2 decades as a significant zoonotic parasite in Europe, with an expanding geographic distribution driven by the spread of lachryphagous drosophilid fruit fly vectors of the genus Phortica. This review synthesizes current knowledge on the taxonomy, epidemiology, biology, genetic diversity, pathogenesis, and control of T. callipaeda, with particular emphasis on its One Health relevance. Molecular studies reveal low but structured genetic variability, characterised by a single predominant haplotype circulating in Europe and high haplotype diversity in Asian populations, reflecting long-term endemicity and distinct transmission dynamics. Clinically, infection can result in ocular irritation ranging from mild conjunctivitis to severe keratitis and corneal ulceration, with dogs acting as the primary domestic reservoir and wildlife sustaining sylvatic transmission cycles. Human infections, though underreported, are increasingly recognised and pose a growing public health concern. Effective management relies on mechanical worm removal, macrocyclic lactone treatment and prevention, and integrated surveillance of animal hosts and vectors. Given the influence of climate change, animal mobility, and environmental factors on vector ecology, coordinated One Health strategies are essential to mitigate the continued spread and zoonotic impact of this emerging eyeworm.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.